Dr. Matthew Scott Salzman, MD

Dr. Salzman practices at Cooper University Hospital in Camden, New Jersey, part of Cooper University Health Care.

Dr. Salzman's NPI, 1659320935, was assigned on May 6, 2006. Dr. Salzman graduated from Jefferson Medical College of Thomas Jefferson University in 2001. Dr. Salzman holds New Jersey license 25MA09086700.

Dr. Salzman's primary practice is Cooper University Hospital, at 1 Cooper Plaza, Camden, NJ 08103 in Camden County. The practice phone is (856) 342-2000.

Dr. Salzman's primary practice is Cooper University Hospital in Camden, New Jersey, part of Cooper University Health Care. The medical group on file is Cooper University Physicians. Dmand AI also links Dr. Salzman to 2 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Salzman practices, 3 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Dr. Salzman's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dmand AI has Dr. Salzman's licenses on file in 2 states: New Jersey and Pennsylvania.

CMS data shows 88 Medicare services from Dr. Salzman across 1 procedure code in 2024, for 115 Medicare patients. Medicare paid $13,454 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 115 Medicare patients who saw Dr. Salzman in 2024. The largest group is 65 to 74, with 45 patients. 75% of them have high blood pressure, and 70% have high cholesterol. 42% are also on Medicaid. Their average risk score is 2.48, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Salzman's median patient age at 49, with 51% women.

In 2024, Dr. Salzman wrote 46 Medicare Part D claims for 23 patients. 98% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $2,238 in total drug cost. In 2023, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Salzman for performance year 2024, reported as part of a group. Dr. Salzman accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 34 papers to Dr. Salzman, published from 2011 to 2024. 2024 was the busiest year, with 8. The most frequent topics are Opioid-Related Disorders, Buprenorphine and Emergency Service, Hospital. Dr. Salzman has published most often in J Addict Med. Dr. Salzman's most frequent co-authors are Lewis Nelson, MD, Samantha Chia-Chih Huo, MD and Christopher A. Milburn, MD.

CMS Open Payments shows 4 general payments to Dr. Salzman from 3 drug and device companies from 2016 to 2017. Food and beverage make up the largest share, 100% of the total. Allergan Inc. paid the most, $49.

Dr. Salzman graduated from Jefferson Medical College of Thomas Jefferson University in 2001.